StockData
Adicet Bio, Inc. logo

Adicet Bio, Inc. (ACET) stock

ACETNasdaqPharmaceutical PreparationsFiscal year ends December 26
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/30
$2.75−0.03 (-1.08%)

Close on Nov 16, 2026Market cap $25.74MP/E –Yield –

Adicet Bio total assets

Total assets on the balance sheet at the end of each period.

Adicet Bio's total assets was $148.17M at Jun 30, 2026. For fiscal 2025 it was $192.36M, down 12.7% from the year before. The highest annual figure on record is $338.94M in fiscal 2021.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$192.36M-12.7%
FY2024Dec 31, 2024$220.22M+6.2%
FY2023Dec 31, 2023$207.30M-37.3%
FY2022Dec 31, 2022$330.69M-2.4%
FY2021Dec 31, 2021$338.94M+120.3%
FY2020Dec 31, 2020$153.84M+88.6%
FY2019Dec 31, 2019$81.59M-25.8%
FY2018Dec 31, 2018$109.94M+99.2%
FY2017Dec 31, 2017$55.19M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$148.17M-9.1%
Q1 FY2026Mar 31, 2026$169.38M-11.4%
Q4 FY2025Dec 31, 2025$192.36M-12.7%
Q3 FY2025Sep 30, 2025$140.48M-42.9%
Q2 FY2025Jun 30, 2025$162.97M-39.4%
Q1 FY2025Mar 31, 2025$191.27M-34.7%
Q4 FY2024Dec 31, 2024$220.22M+6.2%
Q3 FY2024Sep 30, 2024$245.96M+5.4%
Q2 FY2024Jun 30, 2024$268.84M-3.2%
Q1 FY2024Mar 31, 2024$293.10M-3.9%
Q4 FY2023Dec 31, 2023$207.30M-37.3%
Q3 FY2023Sep 30, 2023$233.26M-34.2%
Q2 FY2023Jun 30, 2023$277.63M-15.8%
Q1 FY2023Mar 31, 2023$304.97M-10.4%
Q4 FY2022Dec 31, 2022$330.69M-2.4%
Q3 FY2022Sep 30, 2022$354.30M+37.8%
Q2 FY2022Jun 30, 2022$329.90M+22.7%
Q1 FY2022Mar 31, 2022$340.45M+20.7%
Q4 FY2021Dec 31, 2021$338.94M+120.3%
Q3 FY2021Sep 30, 2021$257.20M+71.0%
Q2 FY2021Jun 30, 2021$268.78M+261.5%
Q1 FY2021Mar 31, 2021$282.07M+260.7%
Q4 FY2020Dec 31, 2020$153.84M+88.6%
Q3 FY2020Sep 30, 2020$150.40M+23.3%
Q2 FY2020Jun 30, 2020$74.34M-45.6%
Q1 FY2020Mar 31, 2020$78.21M-46.1%
Q4 FY2019Dec 31, 2019$81.59M-25.8%
Q3 FY2019Sep 30, 2019$121.96M+3.9%
Q2 FY2019Jun 30, 2019$136.66M+6.1%
Q1 FY2019Mar 31, 2019$145.08M+5.7%
Q4 FY2018Dec 31, 2018$109.94M+99.2%
Q3 FY2018Sep 30, 2018$117.43M–
Q2 FY2018Jun 30, 2018$128.78M–
Q1 FY2018Mar 31, 2018$137.25M–
Q4 FY2017Dec 31, 2017$55.19M–

More Adicet Bio figures

See a number that looks wrong?